Literature DB >> 3948629

Pathological spectrum of liver diseases in sickle cell disease.

M Omata, C S Johnson, M Tong, D Tatter.   

Abstract

Most pathologic studies of liver disease in sickle cell anemia and its variants were performed retrospectively on autopsy specimens, and, because of the prominent histologic features of intrasinusoidal sickling and Kupffer cell erythrophagocytosis, hepatic dysfunction was attributed to the intrahepatic sickling of erythrocytes in this hemoglobinopathy. We compared the liver histology from 19 patients who had liver biopsies to the autopsy specimens from 32 patients who succumbed to the complications of the hemoglobinopathy. In the former, nine patients had histological evidence of viral hepatitis. Four of these patients had both serological and immunohistochemical evidence of hepatitis B surface antigen. The features of biliary tree obstruction were found in two cases and alcoholic cirrhosis and sarcoid granuloma in one case each. Only one patient, who had recovered from septic shock, showed ischemic necrosis. In five patients incidentally biopsied during cholecystectomy, no significant lesions were found. Fourteen of the autopsy specimens showed ischemic necrosis, a result which was significantly different from the biopsy group. Ten cases had no significant morphologic changes other than heavy iron deposits. There were two cases with chronic active hepatitis, two with diffuse fibrosis, and one case each of cirrhosis, acute viral hepatitis, cholestasis, and giant cell hepatitis. Intrahepatic sickling and erythrophagocytosis were seen in almost all specimens and did not correlate with liver disease or transaminase elevation. Other than the patient with septic shock, ischemic necrosis was found only in postmortem material. These histological features may represent red cell destruction rather than the etiology of liver disease in these patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3948629     DOI: 10.1007/bf01318115

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  In vivo study of the sickle cell phenomenon.

Authors:  W N JENSEN; D L RUCKNAGEL; W J TAYLOR
Journal:  J Lab Clin Med       Date:  1960-12

2.  [The liver in sickle cell anemia].

Authors:  T W GREEN; C L CONLEY; M BERTHRONG
Journal:  Bull Johns Hopkins Hosp       Date:  1953-02

3.  Acute granulomatous hepatitis. Occurrence in cytomegalovirus mononucleosis.

Authors:  H L Bonkowsky; R V Lee; G Klatskin
Journal:  JAMA       Date:  1975-09-22       Impact factor: 56.272

4.  Sickle cell hepatopathy.

Authors:  T W Sheehy
Journal:  South Med J       Date:  1977-05       Impact factor: 0.954

5.  Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers.

Authors:  S Hadziyannis; M A Gerber; C Vissoulis; H Popper
Journal:  Arch Pathol       Date:  1973-11

6.  Sickle cell disease and viral hepatitis.

Authors:  E Barrett-Connor
Journal:  Ann Intern Med       Date:  1968-09       Impact factor: 25.391

7.  The liver in sickle cell anemia. A clinical-pathologic study.

Authors:  H J Rosenblate; R Eisenstein; A W Holmes
Journal:  Arch Pathol       Date:  1970-09

8.  Viral hepatitis: a pathologic spectrum.

Authors:  R L Peters
Journal:  Am J Med Sci       Date:  1975 Jul-Aug       Impact factor: 2.378

9.  Phagocytosis of sickle erythrocytes: immunologic and oxidative determinants of hemolytic anemia.

Authors:  R P Hebbel; W J Miller
Journal:  Blood       Date:  1984-09       Impact factor: 22.113

10.  The liver in sickle cell disease. A clinicopathologic study of 70 patients.

Authors:  T W Bauer; G W Moore; G M Hutchins
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

View more
  15 in total

Review 1.  Interventions for treating intrahepatic cholestasis in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Cristina Elena Martí-Amarista
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

Review 2.  Management of liver complications in sickle cell disease.

Authors:  Abid R Suddle
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease.

Authors:  Elizabeth A Manci; Cheryl A Hillery; Carol A Bodian; Zheng G Zhang; Gerard A Lutty; Barry S Coller
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

4.  Hypoxic hepatitis: a challenging diagnosis.

Authors:  Goolab Trilok; Yang Chang Qing; Xu Li-Jun
Journal:  Hepatol Int       Date:  2012-01-15       Impact factor: 6.047

5.  Reversal of liver function without exchange transfusion in sickle cell intrahepatic cholestasis.

Authors:  Nattamol Hosiriluck; Supannee Rassameehiran; Erwin Argueta; Lukman Tijani
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-10

6.  Giant cell hepatitis in adults.

Authors:  L Gábor; K Pál; S Zsuzsa
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

7.  Increased incidence of hepatitis B markers in children with sickle-cell anemia.

Authors:  P O Abiodun; O J Fatunde; K H Flach; T Buck
Journal:  Blut       Date:  1989-03

Review 8.  Liver in systemic disease.

Authors:  Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

9.  Chronic intrahepatic cholestasis in sickle cell disease requiring exchange transfusion.

Authors:  A O'Callaghan; S G O'Brien; M Ninkovic; G P Butcher; C S Foster; J R Walters; I A Roberts
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

10.  An observational study of children with sickle cell disease in Kilifi, Kenya.

Authors:  Manish Sadarangani; Julie Makani; Albert N Komba; Tolu Ajala-Agbo; Charles R Newton; Kevin Marsh; Thomas N Williams
Journal:  Br J Haematol       Date:  2009-07-23       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.